Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
Alimera Sciences, Inc. (ALIM)
Last alimera sciences, inc. earnings: 4/29 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alimerasciences.com/investor-relations
Company Research
Source: GlobeNewswire
Repurchases Series A Preferred Stock, eliminating $24 million liquidation preference for approximately $938,000Completes $12 million private placement of preferred stock and warrants with conversion price and exercise price at 55% premium to the closing share price on March 24, 2023Extends maturity of existing credit facility to April 2028 and interest-only period up to 3 years ATLANTA, March 27, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces a series of strategic transactions bolstering its balance sheet, extending its current term loan facility, and recovering value for common stockholders. Alimera also announces changes to its Board of Directors. On Friday, March 24, 2023, Alimera: Repurchased and retired all of its outstanding Series A Preferred Stock for approxim
Show less
Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALIM alerts
High impacting Alimera Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
ALIM
News
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Alimera Completes Recruitment for its Landmark NEW DAY StudyGlobeNewswire
- Alimera Sciences, Inc. (NASDAQ: ALIM) had its price target lowered by analysts at HC Wainwright from $9.00 to $5.00.MarketBeat
- Alimera jumps 48% on deal with EyePoint for eye disorder therapy Yutiq [Seeking Alpha]Seeking Alpha
- Alimera Acquires U.S. Commercial Rights to YUTIQ®GlobeNewswire
ALIM
Earnings
- 5/15/23 - Miss
ALIM
Analyst Actions
- 4/3/23 - HC Wainwright
ALIM
Sec Filings
- 5/31/23 - Form D/A
- 5/19/23 - Form 3
- 5/19/23 - Form 4
- ALIM's page on the SEC website